Kura Oncology, Inc. · NASDAQ:KURA
Montanova Capital, LLC reported a 9.40% stake in Kura Oncology, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 2, 2025
Montanova Capital, LLC reported a 9.40% stake in Kura Oncology, Inc., 7,561,000 shares, as a passive investor on Mar 31, 2025. Filed May 2, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 7,561,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.40% | 7,561,000 |
| AVERILL MASTER FUND, LTD. | 8.60% | 6,922,080 |
| AARON COWEN | 9.40% | 7,561,000 |
Source
Related
- Kura Oncology, Inc.
- Montanova Capital, LLC
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Feb 13, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026